236 related articles for article (PubMed ID: 10501554)
1. Elevated endogenous cannabinoids in schizophrenia.
Leweke FM; Giuffrida A; Wurster U; Emrich HM; Piomelli D
Neuroreport; 1999 Jun; 10(8):1665-9. PubMed ID: 10501554
[TBL] [Abstract][Full Text] [Related]
2. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.
Leweke FM; Giuffrida A; Koethe D; Schreiber D; Nolden BM; Kranaster L; Neatby MA; Schneider M; Gerth CW; Hellmich M; Klosterkötter J; Piomelli D
Schizophr Res; 2007 Aug; 94(1-3):29-36. PubMed ID: 17566707
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Sarchielli P; Pini LA; Coppola F; Rossi C; Baldi A; Mancini ML; Calabresi P
Neuropsychopharmacology; 2007 Jun; 32(6):1384-90. PubMed ID: 17119542
[TBL] [Abstract][Full Text] [Related]
4. Control of pain initiation by endogenous cannabinoids.
Calignano A; La Rana G; Giuffrida A; Piomelli D
Nature; 1998 Jul; 394(6690):277-81. PubMed ID: 9685157
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.
Giuffrida A; Leweke FM; Gerth CW; Schreiber D; Koethe D; Faulhaber J; Klosterkötter J; Piomelli D
Neuropsychopharmacology; 2004 Nov; 29(11):2108-14. PubMed ID: 15354183
[TBL] [Abstract][Full Text] [Related]
6. Receptor-dependent formation of endogenous cannabinoids in cortical neurons.
Stella N; Piomelli D
Eur J Pharmacol; 2001 Aug; 425(3):189-96. PubMed ID: 11513837
[TBL] [Abstract][Full Text] [Related]
7. Anandamide dysfunction in prodromal and established psychosis.
Leweke FM
Curr Pharm Des; 2012; 18(32):5188-93. PubMed ID: 22716147
[TBL] [Abstract][Full Text] [Related]
8. Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines.
Fontana A; Di Marzo V; Cadas H; Piomelli D
Prostaglandins Leukot Essent Fatty Acids; 1995 Oct; 53(4):301-8. PubMed ID: 8577784
[TBL] [Abstract][Full Text] [Related]
9. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.
Potvin S; Kouassi E; Lipp O; Bouchard RH; Roy MA; Demers MF; Gendron A; Astarita G; Piomelli D; Stip E
J Psychopharmacol; 2008 May; 22(3):262-9. PubMed ID: 18308802
[TBL] [Abstract][Full Text] [Related]
10. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis.
Koethe D; Giuffrida A; Schreiber D; Hellmich M; Schultze-Lutter F; Ruhrmann S; Klosterkötter J; Piomelli D; Leweke FM
Br J Psychiatry; 2009 Apr; 194(4):371-2. PubMed ID: 19336792
[TBL] [Abstract][Full Text] [Related]
11. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.
Giuffrida A; Parsons LH; Kerr TM; Rodríguez de Fonseca F; Navarro M; Piomelli D
Nat Neurosci; 1999 Apr; 2(4):358-63. PubMed ID: 10204543
[TBL] [Abstract][Full Text] [Related]
12. Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture.
Maccarrone M; Attinà M; Cartoni A; Bari M; Finazzi-Agrò A
J Neurochem; 2001 Jan; 76(2):594-601. PubMed ID: 11208922
[TBL] [Abstract][Full Text] [Related]
13. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids as physiological regulators of colonic propulsion in mice.
Pinto L; Izzo AA; Cascio MG; Bisogno T; Hospodar-Scott K; Brown DR; Mascolo N; Di Marzo V; Capasso F
Gastroenterology; 2002 Jul; 123(1):227-34. PubMed ID: 12105851
[TBL] [Abstract][Full Text] [Related]
15. Association of anandamide with altered binocular depth inversion illusion in schizophrenia.
Reuter AR; Bumb JM; Mueller JK; Rohleder C; Pahlisch F; Hanke F; Arens E; Leweke FM; Koethe D; Schwarz E
World J Biol Psychiatry; 2017 Sep; 18(6):483-488. PubMed ID: 27734750
[TBL] [Abstract][Full Text] [Related]
16. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
Skaper SD; Buriani A; Dal Toso R; Petrelli L; Romanello S; Facci L; Leon A
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3984-9. PubMed ID: 8633002
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
Calignano A; La Rana G; Piomelli D
Eur J Pharmacol; 2001 May; 419(2-3):191-8. PubMed ID: 11426841
[TBL] [Abstract][Full Text] [Related]
18. Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum.
Gebeh AK; Willets JM; Marczylo TH; Konje JC
J Matern Fetal Neonatal Med; 2014 Jun; 27(9):954-9. PubMed ID: 24117326
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes.
Bisogno T; Maurelli S; Melck D; De Petrocellis L; Di Marzo V
J Biol Chem; 1997 Feb; 272(6):3315-23. PubMed ID: 9013571
[TBL] [Abstract][Full Text] [Related]
20. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
Wagner JA; Varga K; Ellis EF; Rzigalinski BA; Martin BR; Kunos G
Nature; 1997 Dec; 390(6659):518-21. PubMed ID: 9394002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
